Galmed Pharmaceuticals: Galmed Pharmaceuticals : Consolidated Financial Statements - Form 6-K

(marketscreener.com) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 Under the Securities Exchange Act of 1934 For the Month of November 2023 ...https://www.marketscreener.com/quote/stock/GALMED-PHARMACEUTICALS-LT-16000956/news/Galmed-Pharmaceuticals-Consolidated-Financial-Statements-Form-6-K-45421381/?utm_medium=RSS&utm_content=20231122